Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
US guidelines on prevention with people living with HIV now emphasise engagement with care, HIV treatment and social factors

The American public health agency, the Centers for Disease Control and Prevention (CDC) has published new recommendations on the HIV prevention interventions and advice that should

Published
05 January 2015
By
Roger Pebody
Third of 2015 health basket expansion in Israel goes to hepatitis C

The Israeli Health Ministry will devote 100 million shekels (£16.6m), roughly a third of the NIS 324m (£53.7m). budget for additions to the 2015 health basket, to medications for treating viral hepatitis.

Published
04 January 2015
From
Jerusalem Post
Gilead, Janssen Expand HIV Combo Collaborations

Janssen R&D Ireland and Gilead Sciences have expanded two existing HIV drug collaborations through agreements to develop new once-daily HIV tablets, the companies said today in separate announcements. The value of both collaborations was not disclosed.

Published
30 December 2014
From
Genetic Engineering & Biotechnology News
Gilead Sciences, Inc. Can't Do It Alone

On Monday, Gilead Sciences announced an expanded agreement with Johnson & Johnson to develop two different of cocktail pills to treat HIV. One drug will combine Gilead's tenofovir alafenamide, commonly called TAF, and Emtriva with Johnson & Johnson's Edurant. The other combines Gilead's TAF, Emtriva, and Tybost, along with Janssen's Prezista.

Published
30 December 2014
From
Motley Fool
US: Consumer Group Sues Aetna, Claiming Discrimination Against HIV Patients

A consumer group has sued the health insurer Aetna, claiming that it discriminated against patients with H.I.V. when it required them to obtain medications exclusively through its own mail-order pharmacy.

Published
26 December 2014
From
New York Times
Even with New AbbVie Drug, Many Hepatitis C Patients Are Being Turned Away from Treatment

Even with New AbbVie Drug, Many Hepatitis C Patients Are Being Turned Away from Treatment. Doctors, insurance companies, and even governments have cried foul over high prices the new medications Sovaldi, Harvoni, and now Viekira Pak. Sick people aren’t getting the treatments they need due to insurance denials and other roadblocks.

Published
23 December 2014
From
Hepatitis C News
Gilead slides after hepatitis drug setback

Gilead Sciences shares backtracked from their giddy ascent of the past three years, falling more than 10 per cent after the company’s flagship hepatitis C treatment fell out of favour with the largest pharmacy benefits manager in the US. Express Scripts, which helps manage the cost of healthcare plans offered by companies as well as some government programmes, said it had chosen Viekira Pak, a medicine developed by drugmaker AbbVie, as the “exclusive option” for patients.

Published
23 December 2014
From
Financial Times (free registration required)
South Africa: Silent Suffering - Men and HIV (Video)

Why are South African men reluctant to test for HIV, to start and stay on ART, and to join support groups? Is it that health services are not men-friendly? Is it an idea of masculinity that mandates men to be stoic, to hide pain as a weakness and not to talk about their feelings? What defines the relationship of men to health services and how can it be improved? In this video by Davison Mudzingwa, experts and activists like Thamela, analyze the factors that drive men’s gendered vulnerability to HIV in South Africa and suggest ways to reduce it.

Published
23 December 2014
From
IPS
Hepatitis C patients stage sit-in to demand access to new treatment

Protest at Madrid hospital aims to shame the government into releasing more funds.

Published
20 December 2014
From
El Pais
EXCLUSIVE: Government confirms it will not cut HIV prevention budget

The Government has refuted claims that it was to halve its HIV prevention budget for 2015, reiterating support for the strategy and saying “It will continue”.

Published
20 December 2014
From
PinkNews

Filter by country